A randomized, double blind controlled trial comparing rituximab against intravenous cyclophosphamide in connective tissue diseaese associated interstitial lung disease (RECITAL)

Fordham, Richard (Principal Investigator)
Maher, Toby (Principal Investigator)

Royal Brompton & Harefield NHS Foundation Trust

Status	Finished
Effective start/end date	1/09/13 → 30/06/21

Funding

National Institute for Health and Care Research: £62,602.00

1 Article

Rituximab versus cyclophosphamide for the treatment of connective tissue disease-associated interstitial lung disease (RECITAL): study protocol for a randomised controlled trial
Saunders, P., Tsipouri, V., Keir, G. J., Ashby, D., Flather, M. D., Parfrey, H., Babalis, D., Renzoni, E. A., Denton, C. P., Wells, A. U. & Maher, T. M., 15 Jun 2017, In: Trials. 18, 275.
Research output: Contribution to journal › Article › peer-review

Open Access
File

122 Citations (Scopus)

49 Downloads (Pure)